VCEL

#1768
Vericel Corporation - Common Stock
33.3 3 USD
-2.66%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
33.33
33.33
Faixa anual
0.34
43.00
Mudança diária
-2.66%
Mudança mensal
-0.30%
Mudança em 6 meses
-16.21%
Mudança anual
-8.31%
Fechamento anterior
34.2 4
Open
33.3 3
Mínimo
33.3 3
High
33.3 3
Volume
114
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 1.7 B
  • Employee 398
  • Founded 1989
  • CEO Nick Colangelo
  • Website www.vcel.com
  • Headquarter Michigan, United States
  • FIGI BBG000BDCM24
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
112.53
Índice preço/fluxo de caixa
6.8

Vericel Corporation - Common Stock

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan. In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before. In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts.

Notícias